secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vistagen Therapeutics, Inc. (VTGN)
CIK:        0001411685
Form:       8-K
Filed at:   2025-09-15T23:59:59+00:00
Accession:  0001411685-25-000081
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vistagen CFO Cynthia Anderson resigns effective Oct 15; annual meeting votes ratified
--------------------------------------------------------------------------------

- CFO Cynthia L. Anderson resigns effective Oct 15, 2025; resignation not due to any disagreement with company.
- Company is searching for a successor; intends to enter a consulting agreement with Anderson for transition support.
- Six director nominees elected at annual meeting, including CEO Shawn Singh and Chair Margaret FitzPatrick.
- Non-binding advisory vote on executive compensation (say-on-pay) approved by stockholders.
- Appointment of KPMG as independent auditor for fiscal year ending March 31, 2026 ratified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411685/000141168525000081/0001411685-25-000081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411685/000141168525000081/vtgn-20250909.htm
  HTML page:      https://secwatch.observer/filing/0001411685-25-000081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer